First human tests begin for experimental drug LY3867070
NCT ID NCT07021547
Summary
This is an early safety study to understand how healthy people tolerate a new experimental drug called LY3867070. Researchers will give the drug to 196 healthy volunteers and monitor for side effects while measuring how the body processes it. The study will also check how the drug affects certain genes in some participants through skin samples.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Anaheim Clinical Trials, LLC
NOT_YET_RECRUITINGAnaheim, California, 92801, United States
Contact Phone: •••-•••-••••
Contact
-
Fortrea Clinical Research Unit
RECRUITINGDallas, Texas, 75247, United States
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.